Literature DB >> 15664189

Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor.

Ivan Bosanac1, Haruka Yamazaki, Toru Matsu-Ura, Takayuki Michikawa, Katsuhiko Mikoshiba, Mitsuhiko Ikura.   

Abstract

Binding of inositol 1,4,5-trisphosphate (IP(3)) to the amino-terminal region of IP(3) receptor promotes Ca(2+) release from the endoplasmic reticulum. Within the amino terminus, the first 220 residues directly preceding the IP(3) binding core domain play a key role in IP(3) binding suppression and regulatory protein interaction. Here we present a crystal structure of the suppressor domain of the mouse type 1 IP(3) receptor at 1.8 A. Displaying a shape akin to a hammer, the suppressor region contains a Head subdomain forming the beta-trefoil fold and an Arm subdomain possessing a helix-turn-helix structure. The conserved region on the Head subdomain appeared to interact with the IP(3) binding core domain and is in close proximity to the previously proposed binding sites of Homer, RACK1, calmodulin, and CaBP1. The present study sheds light onto the mechanism underlying the receptor's sensitivity to the ligand and its communication with cellular signaling proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664189     DOI: 10.1016/j.molcel.2004.11.047

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  60 in total

1.  Calcium-dependent conformational changes in inositol trisphosphate receptors.

Authors:  Georgia Anyatonwu; M Tariq Khan; Zachary T Schug; Paula C A da Fonseca; Edward P Morris; Suresh K Joseph
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Tyr-167/Trp-168 in type 1/3 inositol 1,4,5-trisphosphate receptor mediates functional coupling between ligand binding and channel opening.

Authors:  Haruka Yamazaki; Jenny Chan; Mitsuhiko Ikura; Takayuki Michikawa; Katsuhiko Mikoshiba
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

Review 3.  IP(3) receptors: toward understanding their activation.

Authors:  Colin W Taylor; Stephen C Tovey
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-27       Impact factor: 10.005

Review 4.  Toward a high-resolution structure of IP₃R channel.

Authors:  Irina I Serysheva
Journal:  Cell Calcium       Date:  2014-08-10       Impact factor: 6.817

Review 5.  Inositol trisphosphate receptor Ca2+ release channels.

Authors:  J Kevin Foskett; Carl White; King-Ho Cheung; Don-On Daniel Mak
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

6.  Surface accessibility and conformational changes in the N-terminal domain of type I inositol trisphosphate receptors: studies using cysteine substitution mutagenesis.

Authors:  Georgia Anyatonwu; Suresh K Joseph
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

Review 7.  Structure of IP3R channel: high-resolution insights from cryo-EM.

Authors:  Mariah R Baker; Guizhen Fan; Irina I Serysheva
Journal:  Curr Opin Struct Biol       Date:  2017-06-12       Impact factor: 6.809

8.  The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule.

Authors:  Ching-Chieh Tung; Paolo A Lobo; Lynn Kimlicka; Filip Van Petegem
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

9.  Cloning, recombinant production, crystallization and preliminary X-ray diffraction analysis of SDF2-like protein from Arabidopsis thaliana.

Authors:  Jens Radzimanowski; Stephanie Ravaud; Andrea Schott; Sabine Strahl; Irmgard Sinning
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-12-25

10.  Integrins protect cardiomyocytes from ischemia/reperfusion injury.

Authors:  Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.